HJA
GILD icon

Hugh Johnson Advisors’s Gilead Sciences GILD Stock Holding History

Hugh Johnson Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-20,217
Closed -$1.86M – 87
2016
Q1 		$1.86M Buy
20,217
+16
+0.1% +$1.44K 0.73% 48
2015
Q4 		$2.04M Sell
20,201
-389
-2% -$40.5K 0.78% 45
2015
Q3 		$2.02M Sell
20,590
-253
-1% -$28.1K 0.82% 49
2015
Q2 		$2.44M Sell
20,843
-119
-0.6% -$13K 0.86% 45
2015
Q1 		$2.06M Sell
20,962
-230
-1% -$23.4K 0.69% 51
2014
Q4 		$2M Buy
+21,192
New +$2.19M 0.7% 53

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hugh Johnson Advisors's GILD Position: Q2 2016 in Review

Hugh Johnson Advisors sold out of Gilead Sciences (GILD) in Q2 2016, closing a stake of 20,217 shares — an estimated $1.86M sold.

Hugh Johnson Advisors first reported a position in GILD in Q4 2014 and held it in 6 quarters. The position peaked at $2.44M in Q2 2015. 1,596 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

  • Hugh Johnson Advisors reported no remaining Gilead Sciences position as of Q2 2016 after selling out during the quarter.
  • Hugh Johnson Advisors sold 20,217 Gilead Sciences shares in Q2 2016, an estimated $1.86M.
  • Hugh Johnson Advisors first reported a position in Gilead Sciences in Q4 2014 and held it in 6 quarters.
  • Hugh Johnson Advisors's Gilead Sciences position peaked at $2.44M in Q2 2015.
  • 1,596 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on Hugh Johnson Advisors's 13F filing for Q2 2016, filed 4 Aug 2016.